Preclinical antitumor activity of the novel heat shock protein 90 inhibitor CH5164840 against human epidermal growth factor receptor 2 (HER2)-overexpressing cancers
Naomi Ono, Toshikazu Yamazaki, Yoshito Nakanishi, Toshihiko Fujii, Kiyoaki Sakata, Yukako Tachibana, Atsushi Suda, Kihito Hada, Takaaki Miura, Shigeo Sato, Ryoichi Saitoh, Kohnosuke Nakano, Takuo TsukVolume:
103
Year:
2012
Language:
english
Pages:
8
DOI:
10.1111/j.1349-7006.2011.02144.x
File:
PDF, 633 KB
english, 2012